GENOR-B (06998) announced its 2024 annual results, with a net loss of 52.974 million yuan, a year-on-year reduction of 92.2%.

GENOR-B (06998) released its 2024 annual performance, with a revenue of 0.206 billion yuan (Renminbi, the same below), ...

Zhitong FinanceMar 30 06:10 ET

Express News | Genor Biopharma Holdings FY Revenue RMB 206.2 Million

ReutersMar 30 06:05 ET

GENOR-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024

HKEXMar 30 06:05 ET · Announcements

GENOR-B (06998.HK) plans to hold a Board of Directors meeting on March 28 to approve the annual performance.

Gelonghui, on March 18, announced that GENOR-B (06998.HK) will hold a Board of Directors meeting on March 28, 2025 (Friday), to consider and approve the full year performance of the company and its subsidiaries for the year ending December 31, 2024, and its release.

Gelonghui FinanceMar 18 05:19 ET

GENOR-B: DATE OF BOARD MEETING

HKEXMar 18 05:00 ET · Announcements

Express News | Genor Biopharma - Co and Target Are in Course of Preparing New Listing Application

ReutersFeb 25 04:54 ET